INDO BORAX & CHEMICALS LTD.-$

Indo Borax & Chemicals Ltd has appointed Suresh Kalra as Managing Director and CEO, and Shashikant Bharuka as CFO of its recently acquired subsidiary, Kronox Lab Sciences Ltd. This follows Indo Borax's acquisition of a 64.26% stake in Kronox Lab Sciences on September 29. The new leadership aims to strengthen operational synergies and drive growth for Kronox, which reported FY26 revenue of approximately ₹101 crore and PAT of approximately ₹28 crore. The acquisition marks a new phase for Indo Borax, leveraging Kronox's expertise in high-purity specialty chemicals.

Indo Borax & Chemicals Ltd. has announced the completion of its acquisition of a 64.26% stake in Kronox Lab Sciences Limited. The transaction was finalized on September 29, 2026. This strategic acquisition is expected to enhance Indo Borax's market presence and diversify its business operations by integrating Kronox Lab Sciences into its portfolio.

Indo Borax & Chemicals Ltd has announced the closure of its trading window. The window will remain closed until further notice, as per the company's intimation to the stock exchanges. This measure is typically implemented to prevent insider trading during periods when sensitive financial information is being prepared or disseminated.

Indo Borax & Chemicals Ltd has announced that it has availed funding from a lending institution. This funding is specifically earmarked for financing the acquisition of equity shares in Kronox Lab Sciences Limited. The company has made this disclosure to the stock exchanges, adhering to relevant regulations.

Indo Borax & Chemicals Ltd has officially informed the stock exchanges, BSE and NSE, about a change in its corporate office address. The company also stated that its books of account and relevant papers will now be maintained at this new corporate office. The registered office remains at Tulsiani Chambers, Nariman Point, Mumbai. This update is a procedural notification regarding the company's operational base.

Indo Borax & Chemicals Ltd. has signed a Share Purchase Agreement to acquire a 64.26% stake in Vadodara-based speciality chemicals player Kronox Lab Sciences for ₹246.12 crore. The acquisition involves purchasing 2,38,44,000 equity shares of Kronox Lab Sciences at a face value of ₹10 each. Additionally, Indo Borax, along with its promoter Zenrock Chemicals Private Limited, will make an Open Offer to acquire up to 25.79% stake (95,70,000 equity shares) in Kronox Lab Sciences. The transaction is expected to be completed within three months. This strategic move aims to strengthen Indo Borax's offerings, leverage Kronox's export presence, and improve margins. The erstwhile promoters of Kronox will retain a 9.95% stake and provide transition support.

Indo Borax & Chemicals Ltd announced its Board of Directors has approved the acquisition of 2,38,44,000 equity shares, representing 64.26% of Kronox Lab Sciences Limited, from its promoters. The acquisition is valued at ₹103.22 per share, totaling ₹246.12 crore. This transaction will trigger a mandatory open offer to the public shareholders of Kronox Lab Sciences Limited for approximately 25.79% of its share capital, to be made by Indo Borax along with Zenrock Chemicals Private Limited. The acquisition is subject to the terms outlined in the share purchase agreement.

Indo Borax & Chemicals Ltd announced its Board of Directors has approved the acquisition of 2,38,44,000 equity shares, representing 64.26% of Kronox Lab Sciences Limited, from its promoters for an aggregate consideration of ₹246.12 crore. The acquisition price per share is ₹103.22. Concurrently, Indo Borax and Zenrock Chemicals Private Limited will make a mandatory open offer to the public shareholders of Kronox Lab Sciences Limited for up to 95,70,000 equity shares, approximately 25.79% of the voting share capital, at a price to be determined per SEBI regulations. This move signifies a significant strategic expansion for Indo Borax.

Indo Borax & Chemicals Ltd reported a strong first quarter for FY27, with consolidated net profit soaring 59.31% to ₹16.25 crore from ₹10.20 crore in the same period last year. This significant growth was driven by robust demand in the boron-based chemicals market and improved operational efficiencies. Operating income increased by 31.34% to ₹70.36 crore. The company also announced board approval for the amalgamation of its wholly-owned subsidiary, Indoborax Infrastructure Private Ltd, with Indo Borax Chemicals, pending regulatory approvals. The company highlighted strong capacity utilization and expects to sustain its growth momentum.

Indo Borax & Chemicals Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026. The company reported its financial performance for the period, with the results being reviewed by the Audit Committee and approved by the Board of Directors on August 10, 2026. The results have also undergone a limited review by the statutory auditors. The company operates in a single segment, 'Manufacturing and selling of Chemicals'. A scheme of amalgamation of its wholly-owned subsidiary, Indoborax Infrastructure Private Limited, with the company was approved by the Board on July 21, 2026, subject to regulatory approvals.